Key result
Thrombophilia mutations, including factor V Leiden (OR 2.5; 95% CI 0.5-13.5), were not significantly associated with an increased risk of ischaemic stroke in children.
Why the study?
Do thrombophilia mutations (Factor V Leiden, Prothrombin 20210 G->A, MTHFR C677T) increase the risk of ischaemic stroke in children?
Case-Control
Yes
Do thrombophilia mutations (Factor V Leiden, Prothrombin 20210 G->A, MTHFR C677T) increase the risk of ischaemic stroke in children?
Odds Ratio: 2.5 (95% CI 0.5–13.5)
Thrombophilia mutations (Factor V Leiden, Prothrombin 20210 G->A, MTHFR C677T) do not appear to play a significant role in the etiology of childhood ischaemic stroke.
Does not support routine thrombophilia screening in pediatric stroke; leaves open contribution of prothrombin mutation and other factors.
Ischaemic stroke is a rare occurrence in children and in a proportion of cases the aetiology remains unknown. We have investigated the role of thrombophilia in the aetiology of this condition. Of 50 cases identified at two centres, 37 were available for detailed haematological analysis. No cases were identified with deficiencies of antithrombin, protein C or protein S. One case had elevated IgG anticardiolipin antibodies at low titre. The prevalence of the prothrombin 20210 G-->A mutation, factor V Leiden (FVL) mutation and the C677T mutation in the MTHFR gene was compared in cases to that observed in random unselected cord blood controls. The odds ratio for stroke was not significantly increased in carriers of the prothrombin mutation (OR 1.2; 95% CI 0.1-10.7), FVL (OR 2.5; 95% CI 0.5-13.5), or the C677T mutation (OR 1.7; 95% CI 0.6-4.5). Our findings suggest that thrombophilia may not play a significant role in the aetiology of stroke in children, although a large prospective study is required to investigate this area further.
No takes yet. Share an insight, caveat, or question.
Chalmers et al. (1999) conducted a case-control in Childhood ischaemic stroke. Thrombophilia mutations (prothrombin 20210 G-->A, factor V Leiden, MTHFR C677T) vs. Random unselected cord blood controls was evaluated on Ischaemic stroke (OR 2.5, 95% CI 0.5-13.5). Thrombophilia mutations, including factor V Leiden (OR 2.5; 95% CI 0.5-13.5), were not significantly associated with an increased risk of ischaemic stroke in children.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: